APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Applied Therapeutics (NASDAQ:APLT)
LOS ANGELES, Jan. 6, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) APLT for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 …